Metabolic-dysfunction-associated steatotic liver disease (MASLD), formerly known as NAFLD, has quietly become one of the most prevalent chronic liver conditions worldwide. In India, reliable community-level data have been limited, leaving clinicians to extrapolate from hospital-based studies. The Phenome India cohort now offers a clearer picture, and the results are sobering. This large prospective study evaluated over 10,000 adults from 27 cities across India, ultimately analyzing data from 7,764 participants using transient elastography along with detailed metabolic and biochemical profiling.
The cohort included working and retired CSIR employees and their spouses, providing a geographically diverse but relatively homogeneous population in terms of education and socioeconomic status. Nearly 4 in 10 Adults Had MASLD The headline finding is striking. Almost half of the screened…
